Dr. Sanjeev V. Kothare, MD
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
At a glance
- Years since graduation
- 39
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
NY license 268754 -
Clinical Neurophysiology Physician
NY license 268754 -
Sleep Medicine (Psychiatry & Neurology) Physician
NY license 268754
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- North Shore-Lij Medical PC (6,440 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 8 companies reported 24 payments worth $11,596 in total to this clinician.
| UCB SA | $5,864 |
|---|---|
| UCB, Inc. | $5,152 |
| Jazz Pharmaceuticals Inc. | $357 |
| Acadia Pharmaceuticals Inc | $58.86 |
| Biocodex, Inc. | $52.01 |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.28 |
| Axsome Therapeutics, Inc. | $37.71 |
| Neuropace, Inc. | $28.73 |
| Consulting Fee | $9,989 |
|---|---|
| Food and Beverage | $1,228 |
| Travel and Lodging | $379 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB SA Mar 14, 2025 | Consulting Fee Fintepla · Neurology | $4,764 |
| UCB, Inc. Dec 24, 2025 | Consulting Fee Fintepla · Neurology | $4,125 |
| UCB SA Jun 20, 2025 | Consulting Fee Fintepla · Neurology | $1,100 |
| UCB, Inc. Dec 4, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA · in-kind | $270 |
| UCB, Inc. Dec 24, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA | $60.43 |
| UCB, Inc. Dec 24, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA | $33.23 |
| UCB, Inc. Dec 24, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA | $15.45 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $8,829 in research payments for these studies, mostly to the institutions running them.
- A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
UCB SA · Enrolling by invitation · NCT05076617
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.